Category: Money tips Release Date: 2006-04-18
Although the A-share market in the recent trend of a sustained wide shocks, but the medicine was repeated shocks stocks strong, Pien Tze Huang, Tong Ren Tang, Holley varieties of medicine, and so have the impact of limit-board, and so on makes the medicine with the Shanghai Composite index runs counter to the pharmaceutical industry index has accelerated the formation of a unilateral trend, it appears that pharmaceutical stocks are expected to become the market of new investment products.
Development opportunities facing the pharmaceutical industry
In 2006, the pharmaceutical industry is facing troubled times, particularly in the pharmaceutical system, increase efforts to crack down on commercial bribery medicine, drug price cuts and other listed companies in the pharmaceutical industry led the growth of facing a great challenge. This could also be medical unit in 2006 is not able to outperform one of the reasons.
However, in 2007, the dawn of the development prospects of the pharmaceutical industry increasingly clear up, first through the 2006 restructuring of the pharmaceutical industry, industry consolidation is more conducive to large-scale pharmaceutical enterprises, thereby creating competition in the pharmaceutical industry to bring a very positive changes in the pattern of . Second, more and more clear the direction of medical reform, for example, doctors change the drugs to support the pharmaceutical industry pattern, generic prescription system has been promoted, will greatly for high-quality pharmaceutical manufacturers a competitive advantage status. For example, the Government will again come up with 150 billion yuan every year to subsidize the health care system, such information is a reflection of the pharmaceutical industry will face a great opportunity for development.
Moreover, the pharmaceutical industry data also shows that pharmaceutical companies listed investment opportunities to come for that since the second half of 2006 has changed the pharmaceutical industry continued to decline in the 18-month growth trend, while there clear signs of recovery in the economy , especially in October, 11 months of industry data is even more optimistic about the return on sales is from July's 7.49% up to November's 7.81 percent, 0.32 percentage points raised. And because in December 2006, January 2007 collapse in oil prices will further enhance the chemical raw materials gross margins, therefore, the pharmaceutical industry valuation levels will increase rapidly.
Pharmaceutical shares of capital back
The industry information Jiuji sector capital to bring a great deal of confidence, which will enable organizations to fund even more optimistic about the development prospects of the pharmaceutical industry, because with the advent of China's aging population on health, as well as attention to the needs of the pharmaceutical industry will take place larger changes, especially medical care, medical equipment and many other sub-sectors will receive a broader room for growth. More importantly, industry information will also be a great change in the valuation of funds to promote the sector is expected to change, for example, will present the report of health-care industry analysts as a consumer products to look at in order to give a higher estimate the value premium, such a view, the pharmaceutical industry will not only face the industry development opportunities, will also be faced with changes in market valuation of corporate treasurers to bring investment opportunities.
Moreover, the current A-share market capital is also undergoing taste mouth quietly changed, because the expected strengthening of macro-control, such as real estate stocks to allow institutions to finance the land value-added tax was quite cold, so pulled out a close with the macro-control-related industries, such as real estate stocks, banking stocks, steel stocks and cement stocks. The withdrawal of funds in the bull market trend has not changed fundamentally under the premise that they would look into the impact of macro-control of free blocks in the pharmaceutical stocks, it is the case, obviously the disk sector capital return characteristics of pharmaceutical stocks, pharmaceutical stocks The boom has also shown a significant market, not just the pharmaceutical industry's index peaked again and again high, and the dark horse stock constantly Apeloa, modern pharmaceuticals, medicine, and so stocks Holley the case today.
Focus on three types of stocks
Because of this, I suggest that investors focus on the present three types of stocks, first class medical device stocks, because as the rural health system reform, and global medical device industry, the transfer to our country, then the medical device industry will face great opportunity for development, therefore, Wandong Medical, Neusoft shares, Xinhua medical care may be an active interest in individual stocks.
Second, a vaccine-related stocks, including the Temple of Heaven biological, Chongqing beer, human vaccines, but also including animal husbandry and shares Jinyu Group, the days of biological and other animal health vaccines, including vaccines for animals even broader market capacity, not only is the pet market for vaccines start-started to become a listed company related to new profit growth point, but also in animal husbandry industry in the development of animal vaccines to give a broader space for development, because the presence of animal husbandry industry, making animal vaccines are "fast moving consumer goods" characteristics, Therefore, in animal husbandry and shares Tiankang biology, Jinyu Group and other stocks that bargain-hunting can be a positive hold.
Third, have a strong R & D capabilities of pharmaceutical stocks. Because the core competitiveness of Chinese Medicine Unit is the development of new products, only the continuous new product, it has continued to grow. And pharmaceutical stocks also rely mainly on drugs continues to grow reserves, it is suggested investors to pay close attention to the real medicine, modern pharmaceuticals, Tong Ren Tang and other high-quality varieties of listed companies, In addition, Pien Tze Huang, Jinling Pharmaceutical Co., Yunnan Baiyao, ST Zhong Yan unique advantages such as the medical unit can also be tracked.
